ICAM-2/CD102 Antibodies
We offer ICAM-2/CD102 Antibodies for use in common research applications: Adhesion Blockade, ELISA, Flow Cytometry, Functional, Immunocytochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin, Immunoprecipitation, In vitro assay, Western Blot. Each ICAM-2/CD102 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our ICAM-2/CD102 Antibodies can be used in a variety of model species: Human, Mouse, Rat. Use the list below to choose the ICAM-2/CD102 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our ICAM-2/CD102 polyclonal antibodies and browse our ICAM-2/CD102 monoclonal antibody catalog.
Alternate Names for ICAM-2/CD102 Antibodies
anti-ICAM-2/CD102 antibody, anti-ICAM2 antibody, anti-CD102 antibody, anti-CD102 antigen antibody, anti-ICAM-2 antibody, anti-intercellular adhesion molecule 2 antibody
15 Results for "icam-2-cd102" in Primary Antibodies
![ICAM-2 WT and variants co-precipitated with alpha -actinin. A) IP/IB experiments with control cell lines demonstrate the expected association of ICAM-2, alpha -actinin and actin in lysates from SK-N-ASpIRES.ICAM-2 cells (labeled as WT), but not SK-N-ASpIRESneo cells (neo). Results for these control cell lines were published previously [13]. B) ICAM-2 glycosylation site variants associated simultaneously with alpha -actinin and actin. Immunoprecipitations (IP) were performed using whole cell lysates and a mouse monoclonal antibody to alpha -actinin (MAB1682, Millipore). Following protein separation by electrophoresis, immunoblots (IB) were performed with antibodies to alpha -actinin (sc-7454, Santa Cruz Biotech), ICAM-2 (AF244, R&D Systems), or actin (4968, Cell Signaling). The presence of ICAM-2 WT and variants in each preparation was confirmed by immunoblot analysis of input preparations (a representative blot is shown in Figure 2C) and also by immunoblot analysis of the proteins remaining in the supernatant following precipitation (not shown), to confirm the presence of sufficient/excess ICAM-2 protein or variant in each preparation used for immunoprecipitation experiments. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23714211), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/af244_human-icam-2-cd102-affinity-purified-polyclonal-ab-8220249503222.jpg "ICAM-2 WT and variants co-precipitated with alpha -actinin. A) IP/IB experiments with control cell lines demonstrate the expected association of ICAM-2, alpha -actinin and actin in lysates from SK-N-ASpIRES.ICAM-2 cells (labeled as WT), but not SK-N-ASpIRESneo cells (neo). Results for these control cell lines were published previously [13]. B) ICAM-2 glycosylation site variants associated simultaneously with alpha -actinin and actin. Immunoprecipitations (IP) were performed using whole cell lysates and a mouse monoclonal antibody to alpha -actinin (MAB1682, Millipore). Following protein separation by electrophoresis, immunoblots (IB) were performed with antibodies to alpha -actinin (sc-7454, Santa Cruz Biotech), ICAM-2 (AF244, R&D Systems), or actin (4968, Cell Signaling). The presence of ICAM-2 WT and variants in each preparation was confirmed by immunoblot analysis of input preparations (a representative blot is shown in Figure 2C) and also by immunoblot analysis of the proteins remaining in the supernatant following precipitation (not shown), to confirm the presence of sufficient/excess ICAM-2 protein or variant in each preparation used for immunoprecipitation experiments. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23714211), licensed under a CC-BY license. Not internally tested by R&D Systems.")
![ICAM-2 WT and variants co-precipitated with alpha -actinin. A) IP/IB experiments with control cell lines demonstrate the expected association of ICAM-2, alpha -actinin and actin in lysates from SK-N-ASpIRES.ICAM-2 cells (labeled as WT), but not SK-N-ASpIRESneo cells (neo). Results for these control cell lines were published previously [13]. B) ICAM-2 glycosylation site variants associated simultaneously with alpha -actinin and actin. Immunoprecipitations (IP) were performed using whole cell lysates and a mouse monoclonal antibody to alpha -actinin (MAB1682, Millipore). Following protein separation by electrophoresis, immunoblots (IB) were performed with antibodies to alpha -actinin (sc-7454, Santa Cruz Biotech), ICAM-2 (AF244, R&D Systems), or actin (4968, Cell Signaling). The presence of ICAM-2 WT and variants in each preparation was confirmed by immunoblot analysis of input preparations (a representative blot is shown in Figure 2C) and also by immunoblot analysis of the proteins remaining in the supernatant following precipitation (not shown), to confirm the presence of sufficient/excess ICAM-2 protein or variant in each preparation used for immunoprecipitation experiments. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23714211), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/af244_human-icam-2-cd102-affinity-purified-polyclonal-ab-44202415425087.jpg)
![Western Blot: ICAM-2/CD102 Antibody [NBP1-31612] - Sample(30 ug whole cell lysate)A:HeLa S3 12% SDS PAGE, antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-Western-Blot-NBP1-31612-img0005.jpg "Western Blot: ICAM-2/CD102 Antibody [NBP1-31612] - Sample(30 ug whole cell lysate)A:HeLa S3 12% SDS PAGE, antibody diluted at 1:1000.")
![Immunohistochemistry-Paraffin: ICAM-2/CD102 Antibody [NBP1-31612] - Paraffin-embedded breast cancer, using antibody at 1:100 dilution.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-Immunohistochemistry-Paraffin-NBP1-31612-img0004.jpg)
![Western Blot: ICAM-2/CD102 Antibody [NBP2-16912] - Sample (30 ug of whole cell lysate) A: K562 7. 5% SDS PAGE gel, diluted at 1:3000.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-Western-Blot-NBP2-16912-img0003.jpg "Western Blot: ICAM-2/CD102 Antibody [NBP2-16912] - Sample (30 ug of whole cell lysate) A: K562 7. 5% SDS PAGE gel, diluted at 1:3000.")
![Immunocytochemistry/Immunofluorescence: ICAM-2/CD102 Antibody [NBP2-16912] - K562 cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: ICAM2 protein stained by ICAM2 antibody [N1C3] diluted at 1:500. Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-16912-img0002.jpg)
![Western Blot: ICAM-2/CD102 Antibody [NBP2-32236] - Samples: Whole cell lysate (50 ug) from HeLa, 293T, and Jurkat cells. Antibodies: Affinity purified rabbit anti-ICAM-2 antibody NBP2-32236 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-Western-Blot-NBP2-32236-img0001.jpg "<b>Biological Strategies Validation. </b>Western Blot: ICAM-2/CD102 Antibody [NBP2-32236] - Samples: Whole cell lysate (50 ug) from HeLa, 293T, and Jurkat cells. Antibodies: Affinity purified rabbit anti-ICAM-2 antibody NBP2-32236 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Flow Cytometry: ICAM-2/CD102 Antibody (B-T1) [NBP3-14603] - A typical staining pattern with the B-T1 monoclonal antibody of lymphocytes.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-B-T1-Flow-Cytometry-NBP3-14603-img0001.jpg "Flow Cytometry: ICAM-2/CD102 Antibody (B-T1) [NBP3-14603] - A typical staining pattern with the B-T1 monoclonal antibody of lymphocytes.")
![Western Blot: ICAM-2/CD102 Antibody (055) [NBP2-89425] - Lane A: Hela S3 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:31 kDa Observed band size:31 kDa (We are unsure as to the identity of these extra bands.)](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-055-Western-Blot-NBP2-89425-img0001.jpg "Western Blot: ICAM-2/CD102 Antibody (055) [NBP2-89425] - Lane A: Hela S3 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:31 kDa Observed band size:31 kDa (We are unsure as to the identity of these extra bands.)")
![Western Blot: ICAM-2/CD102 Antibody (033) [NBP2-89423] - Lane A: HelaS3 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:31 kDa Observed band size:37 kDa](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-033-Western-Blot-NBP2-89423-img0001.jpg "Western Blot: ICAM-2/CD102 Antibody (033) [NBP2-89423] - Lane A: HelaS3 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:31 kDa Observed band size:37 kDa")
![Immunoprecipitation: ICAM-2/CD102 Antibody [NBP2-32237] - Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from Jurkat cells. Antibodies: Affinity purified rabbit anti-ICAM-2 antibody NBP2-32237 used for IP at 6 ug per reaction. For blotting immunoprecipitated ICAM-2 was used at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-Immunoprecipitation-NBP2-32237-img0001.jpg "Immunoprecipitation: ICAM-2/CD102 Antibody [NBP2-32237] - Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from Jurkat cells. Antibodies: Affinity purified rabbit anti-ICAM-2 antibody NBP2-32237 used for IP at 6 ug per reaction. For blotting immunoprecipitated ICAM-2 was used at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Western Blot: ICAM-2/CD102 Antibody (041) [NBP2-89424] - Lane A: HL60 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:32 kDa Observed band size:41 kDa](http://images.novusbio.com/fullsize/ICAM-2-CD102-Antibody-041-Western-Blot-NBP2-89424-img0001.jpg "Western Blot: ICAM-2/CD102 Antibody (041) [NBP2-89424] - Lane A: HL60 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:32 kDa Observed band size:41 kDa")